These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 30507913)

  • 1. Enrich and Expand Rare Antigen-specific T Cells with Magnetic Nanoparticles.
    Hickey JW; Schneck JP
    J Vis Exp; 2018 Nov; (141):. PubMed ID: 30507913
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biodegradable Cationic Polymer Blends for Fabrication of Enhanced Artificial Antigen Presenting Cells to Treat Melanoma.
    Rhodes KR; Isser A; Hickey JW; Ben-Akiva E; Meyer RA; Kosmides AK; Livingston NK; Tzeng SY; Schneck JP; Green JJ
    ACS Appl Mater Interfaces; 2021 Feb; 13(7):7913-7923. PubMed ID: 33573372
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development of third generation anti-EGFRvIII chimeric T cells and EGFRvIII-expressing artificial antigen presenting cells for adoptive cell therapy for glioma.
    Sahin A; Sanchez C; Bullain S; Waterman P; Weissleder R; Carter BS
    PLoS One; 2018; 13(7):e0199414. PubMed ID: 29975720
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficient magnetic enrichment of antigen-specific T cells by engineering particle properties.
    Hickey JW; Isser AY; Vicente FP; Warner SB; Mao HQ; Schneck JP
    Biomaterials; 2018 Dec; 187():105-116. PubMed ID: 30312851
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nanoscale artificial antigen presenting cells for cancer immunotherapy.
    Rhodes KR; Green JJ
    Mol Immunol; 2018 Jun; 98():13-18. PubMed ID: 29525074
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Engineering artificial antigen-presenting cells to express a diverse array of co-stimulatory molecules.
    Suhoski MM; Golovina TN; Aqui NA; Tai VC; Varela-Rohena A; Milone MC; Carroll RG; Riley JL; June CH
    Mol Ther; 2007 May; 15(5):981-8. PubMed ID: 17375070
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Artificial antigen-presenting cells expressing HLA class II molecules as an effective tool for amplifying human specific memory CD4(+) T cells.
    Garnier A; Hamieh M; Drouet A; Leprince J; Vivien D; Frébourg T; Le Mauff B; Latouche JB; Toutirais O
    Immunol Cell Biol; 2016 Aug; 94(7):662-72. PubMed ID: 26924643
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biologically Inspired Design of Nanoparticle Artificial Antigen-Presenting Cells for Immunomodulation.
    Hickey JW; Vicente FP; Howard GP; Mao HQ; Schneck JP
    Nano Lett; 2017 Nov; 17(11):7045-7054. PubMed ID: 28994285
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Particle-Based Artificial Antigen-Presenting Cell Systems for T Cell Activation in Adoptive T Cell Therapy.
    Hou F; Guo Z; Ho MT; Hui Y; Zhao CX
    ACS Nano; 2024 Mar; 18(12):8571-8599. PubMed ID: 38483840
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [In vitro cytotoxic effects of CML28 specific T cells on acute leukemia cells].
    Mao HW; Liu WL; Zhou JF; Geng Z; Huang W
    Zhonghua Xue Ye Xue Za Zhi; 2009 Feb; 30(2):121-4. PubMed ID: 19563024
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Artificial antigen presenting cells that express prevalent HLA alleles: A step towards the broad application of antigen-specific adoptive cell therapies.
    Hasan AN; Selvakumar A; Doubrovina E; Riviere I; Sadelain MW; O'Reilly RJ
    Discov Med; 2009 Dec; 8(43):210-8. PubMed ID: 20040272
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficient amplification of melanoma-specific CD8+ T cells using artificial antigen presenting complex.
    Chang J
    Exp Mol Med; 2006 Dec; 38(6):591-8. PubMed ID: 17202834
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Artificial antigen-presenting cells expressing CD80, CD70, and 4-1BB ligand efficiently expand functional T cells specific to tumor-associated antigens.
    Zeng W; Su M; Anderson KS; Sasada T
    Immunobiology; 2014 Aug; 219(8):583-92. PubMed ID: 24713579
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 4-1BB is superior to CD28 costimulation for generating CD8+ cytotoxic lymphocytes for adoptive immunotherapy.
    Zhang H; Snyder KM; Suhoski MM; Maus MV; Kapoor V; June CH; Mackall CL
    J Immunol; 2007 Oct; 179(7):4910-8. PubMed ID: 17878391
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Particle shape dependence of CD8+ T cell activation by artificial antigen presenting cells.
    Sunshine JC; Perica K; Schneck JP; Green JJ
    Biomaterials; 2014 Jan; 35(1):269-277. PubMed ID: 24099710
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nanoengineering approaches to the design of artificial antigen-presenting cells.
    Sunshine JC; Green JJ
    Nanomedicine (Lond); 2013 Jul; 8(7):1173-89. PubMed ID: 23837856
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Microfabricated platforms to modulate and monitor T cell synapse assembly.
    Jung HR; Choi JC; Cho W; Doh J
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2013; 5(1):67-74. PubMed ID: 22927231
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adaptive Nanoparticle Platforms for High Throughput Expansion and Detection of Antigen-Specific T cells.
    Hickey JW; Isser A; Salathe SF; Gee KM; Hsiao MH; Shaikh W; Uzoukwu NC; Bieler JG; Mao HQ; Schneck JP
    Nano Lett; 2020 Sep; 20(9):6289-6298. PubMed ID: 32594746
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Artificial antigen-presenting cells transduced with telomerase efficiently expand epitope-specific, human leukocyte antigen-restricted cytotoxic T cells.
    Dupont J; Latouche JB; Ma C; Sadelain M
    Cancer Res; 2005 Jun; 65(12):5417-27. PubMed ID: 15958591
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Induction of human cytotoxic T lymphocytes by artificial antigen-presenting cells.
    Latouche JB; Sadelain M
    Nat Biotechnol; 2000 Apr; 18(4):405-9. PubMed ID: 10748520
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.